Renal Replacement Therapy-Reference-Cited by-同舟云学术

Renal Replacement Therapy

Published:2020 Issue: Volume: Page:469-475
ISSN:
Container-title:ICU Protocols
language:
Short-container-title:

Author:

Prakash Sunil,Majumdar Arghya,Mishra Bhanu

Publisher

Springer Singapore

Link

http://link.springer.com/content/pdf/10.1007/978-981-15-0898-1_47

Reference5 articles.

1. Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med. 2008;36(2):610617. Numerous issues related to study design, conduct, and quality that dispute the validity and question any inferences can be drawn from these trials. In the context of these limitations, the initial RRT modality did not seem to affect mortality or recovery to RRT independence. There is urgent need for additional high-quality and suitably powered trials to adequately address this issue.

2. Casey ET, Gupta BP, Erwin PJ, Montori VM, Murad MH. The dose of continuous renal replacement therapy for acute renal failure: a systematic review and meta-analysis. Ren Fail. 2010;32(5):555–61. Systematic review on the subject. Increased dosing of CRRT was not associated with a decrease in mortality of patients with ARF in an intensive care unit setting.

3. Davenport A. Renal replacement therapy in acute kidney injury: which method to use in the intensive care unit? Saudi J Kidney Dis Transpl. 2008;19(4):529–36. Comprehensive review on the subject. The choice of RRT modality should be guided by the individual patients’ clinical status, the medical and nursing expertise in the local intensive care unit, and the availability of RRT modality.

4. Fieghen H, Wald R, Jaber BL. Renal replacement therapy for acute kidney injury. Nephron Clin Pract. 2009;112(4):c222–9. Recent trials indicate that continuous renal replacement therapy does not confer a survival advantage as compared to intermittent hemodialysis. Furthermore, there is no evidence to support a more intensive strategy of renal replacement therapy in the setting of AKI. There is comparatively limited data regarding the ideal timing of renal replacement therapy initiation and the preferred mode of solute clearance.

5. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356(9223):26–30. Klaus Kogelmann, Dominic Jarczak, Morten Scheller and Matthias Druner. Hemoadsorption by CytoSorb in septic patients: a case series. Critical care 2017, biomedcentral.com . doi.org/10.1186/s13054-017-1662-9 .